Abstract | GU Oncology Now

Abstract

Quality of Life, Efficacy, and Safety of Sequential Intravesical Gemcitabine + Docetaxel versus BCG for Non-Muscle Invasive Urinary Bladder Cancer: A Pilot Study

GU Oncology Now EditorsNon-Muscle Invasive Urothelial Carcinoma | June 3, 2022

...

Genomic biomarkers to guide precision radiotherapy in prostate cancer

GU Oncology Now EditorsRLT | June 3, 2022

...

Rapid SAR optimization for hyperthermic oncology: combining multi-goal optimization and time-multiplexed steering for hotspot suppression

GU Oncology Now EditorsUrothelial Carcinoma | June 3, 2022

...

Germline genetics of prostate cancer

GU Oncology Now EditorsProstate Cancer | June 3, 2022

...

Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma

GU Oncology Now EditorsAdvanced Urothelial Carcinoma | September 26, 2022

...

Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancer

GU Oncology Now EditorsCRPC | June 3, 2022

...

Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes

GU Oncology Now EditorsNon-Muscle Invasive Urothelial Carcinoma | June 3, 2022

...

The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer

GU Oncology Now EditorsProstate Cancer | June 3, 2022

...

Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor

GU Oncology Now EditorsRenal Cell Carcinoma | June 3, 2022

...

ATP-gated P2X7 receptor as a potential target for prostate cancer

GU Oncology Now EditorsProstate Cancer | June 3, 2022

...

Comprehensive Pan-Cancer Analysis Reveals the Role of UHRF1-Mediated DNA Methylation and Immune Infiltration in Renal Cell Carcinoma

GU Oncology Now EditorsRenal Cell Carcinoma | June 3, 2022

...

Expression profiles of the genes associated with zinc homeostasis in normal and cancerous breast and prostate cells

GU Oncology Now EditorsProstate Cancer | June 3, 2022

...

Clinical Effect of Retroperitoneal Laparoscopic Radical Nephrectomy on Renal Cell Carcinoma, the Influence of Renal Function, and the Influencing Factors of Recurrence

GU Oncology Now EditorsRenal Cell Carcinoma | September 13, 2022

RLRN has been widely used in the surgical treatment of renal cancer due to small wound, less bleeding, and rapid recovery.

Rhenium(I) conjugates as tools for tracking cholesterol in cells

GU Oncology Now EditorsProstate Cancer | June 3, 2022

...

Development of a Phagocytosis-Dependent Gene Signature to Predict Prognosis and Response to Checkpoint Inhibition in Clear-Cell Renal Cell Carcinoma

GU Oncology Now EditorsRenal Cell Carcinoma | June 3, 2022

...

An update on the current epidemiological status of metastatic neoplasms to the thyroid

GU Oncology Now EditorsRenal Cell Carcinoma | June 3, 2022

...

Tanshinone IIA exerts autophagic cell death through down-regulation of β-catenin in renal cell carcinoma cells

GU Oncology Now EditorsRenal Cell Carcinoma | June 3, 2022

...

Intratumoral resolution of driver gene mutation heterogeneity in renal cancer using deep learning

GU Oncology Now EditorsRenal Cell Carcinoma | June 3, 2022

...

Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate

GU Oncology Now EditorsUrothelial Carcinoma | June 3, 2022

...

Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS study

GU Oncology Now EditorsmCSPC | October 12, 2023

...